To investigate the hypothesis that neutrophil proteases stimulate airway gland secretion, we studied the effect of human cathepsin G and elastase on secretion of 35S-labeled macromolecules from cultured bovine airway gland serous cells. Both proteases stimulated secretion in a concentration-dependent fashion with a threshold of 2 10-10 M. Elastase was more potent than cathepsin G, causing a maximal secretory response of 1,810±60% over baseline at 10-M. The maximal response to cathepsin G (1,810±70% over baseline at 10-7 M) was similar to the maximal response to elastase. These responses were > 10-fold larger thap the response to other agonists'such as histamine. Protease-induced secretion was noncytotoxic and required catalytically active enzymes. The predominant sulfated macromolecule released by proteases was chondroitin sulfate proteoglycan. Immunocytochemical staining demonstrated chondroitin sulfate in cytoplasmic granules and decreased granular staining after stimulation of cells with elastase. The neutrophil proteases also degraded the proteoglycan released from serous cells. Cathepsin G and elastase in supernatant obtained by degranulation of human peripheral neutrophils also caused a secretory response. Thus, neutrophil proteases stimulate airway gland serous cell secretion of chondroitin sulfate proteoglycan and degrade the secreted product. These findings suggest a potential role for neutrophil proteases in the pathogenesis of increased and abnormal submucosal gland secretions in diseases associated with inflammation and neutrophil infiltration of. the airways. (J. Clin. Invest. 1990. 85:682-689.) serine proteases * exocytosis * chondroitin sulfate proteoglycan
Introduction
Neutrophils are thought to play a major role in generating the pathologic manifestations of airway inflammation, whose features include increased and abnormal airway secretions. Air-cigarette smokers than in nonsmokers (1, 2) , and are greatly increased in the purulent respiratory tract secretions of patients with chronic bronchitis and cystic fibrosis. Environmental stimuli such as ozone and sulfur dioxide, which cause an influx of neutrophils into the airways (3) (4) (5) (6) can also be associated with bronchitis and hypersecretion (5, 7) . Neutrophils are a source of a variety of potentially important mediators of inflammation, including neutral proteases. Prominent among these are the lysosomal proteases cathepsin G and elastase, which are released from neutrophils during phagocytosis and cell death (8,' 9) . Levels of catalytically active cathepsin G and elastase are negligible in normal airway secretions, but are greatly increased in purulent airway secretions. In patients with cystic fibrosis, for example, concentrations of neutrophil elastase in sputum may exceed 100 Atg/ml (3. 3 X 10-6 M) (10, 1 1). Free neutrophil protease activity may also be present in the airways of cigarette smokers and individuals with bronchitis (12) (13) (14) (15) (16) . Neutrophils also infiltrate tissue lying beneath the airway mucosal surfade in these conditions, where they may interact with subepithelial structures involved in secretion, e.g., submucosal glands. Inflammation of submucosal glands has been associated with continuing mucus hypersecretion in ex-smokers' (17) .
Several lines of evidence arising from the study of surface airway epithelial cells suggest a connection between the release of neutrophil proteases and pathologic alterations in secretion. For example, neutrophil elastase causes goblet cell discharge in hamsters in vivo (18) and releases cell surface glycoconjugates from tracheal surface epithelial cells of dogs and guinea pigs in vitro (19) (20) (21) . However, in humans the greatest contribution to airway secretions is thought to originate from submucosal gland secretory cells whose volume is 40 times that of goblet cells in normal airways (22) . In chronic bronchitis and cystic fibrosis, the predominance of submucosal gland secretory cells is even more striking due to the gland hypertrophy and hyperplasia associated with these conditions (22, 23) . However, the effect of neutrophil proteases on airway submucosal gland secretion has not been examined. Therefore, the current'study was designed to examine the hypothesis that neutrophil proteases stimulate secretion of airway submucosal glands. The incentive for these studies was our previous finding that chymase, a chymotrypsin-like mast cell protease closely related to neutrophil cathepsin G, degranulates tracheal gland serous cells (24). Our studies used a cultured line of bovine tracheal gland serous cells that maintains characteristics of differentiated serous cells (25) (26) (27) . The current findings demonstrate that both neutrophil cathepsin G and elastase are potent noncytotoxic serous cell secretagogues that degrade the chondroitin sulfate proteoglycan whose secretion they stimulate.
in 5% C02/95% air. The medium was changed every 3 d.
Release of35S-labeled macromolecules. On day 9 confluent monolayers were incubated with medium containing Na25SO4 (7.5 ,Ci/ml). mg/liter sodium azide to remove unincorporated 3SO4-. Nondialyzable 35S-labeled macromolecules were counted after addition of scintillation fluid (Hydrofluor; National Diagnostics, Inc., Somerville, NJ) by scintillation spectroscopy to an accuracy of 2% (beta counter model LS7500; Beckman Instruments, Inc., Palo Alto, CA).
Secretion is expressed as percent increase of release of 35S-labeled macromolecules during incubation with the agonists over the release during the immediately preceding time period and was corrected for the declining baseline (determined in controls incubated with medium alone).
Analysis of cellular and secreted radiolabeled macromolecules.
Serous cells were cultured and labeled, and the label was chased as described above. After incubation with proteases or medium alone, the spent medium was collected and cooled rapidly. Cell monolayers were washed three times with PBS and dissolved in 4 M guanidine chloride, 0.5% 3-[(3-cholamidopropyl)dimethylammonio]-l-propane sulfonate (CHAPS)', and 0.1 M sodium acetate (pH 6.0). Soybean trypsin inhibitor (final concentration, I mg/ml) and a,-proteinase inhibitor (final concentration, 0.1 mg/ml) were added to all samples to minimize possible degradation of macromolecules by remaining proteases. The samples were dialyzed, lyophilized, and stored at -20°C.
Gel filtration chromatography was performed on a Superose 6 column (Pharmacia Fine Chemicals, Piscataway, NJ). Samples were eluted under dissociative conditions (4 M guanidine chloride, 0.5% CHAPS, 0.1 M sodium acetate; pH 6.0) to dissociate ionic bonds and disaggregate proteoglycans (29) . 0.5-ml fractions were collected, and aliquots were counted for radioactivity after addition of scintillant.
1. Abbreviations used in this paper: CHAPS, 3-[(3-cholamidopropyl) dimethylammonio]-l-propanesulfonate; LDH, lactic acid dehydrogenase.
To identify the nature of the radiolabeled glycoconjugates, the fractions containing radiolabeled material were pooled, dialyzed, and lyophilized again. Aliquots were subjected to gel filtration chromatography after digestion with chondroitinase ABC or chondroitinase AC (0.5 U/ml) or after incubation with the buffer (0.1 M Tris-acetate, pH 7. 3) alone at 370C for 18 h.
Analysis ofcytotoxicity. Possible cytotoxicity of neutrophil cathepsin G and elastase (each l0-7 M) was determined by measurements of the release of lactic acid dehydrogenase (LDH) and by vital dye exclusion. Serous cells were seeded in human placental collagen-coated 6-well tissue culture plates (10 cm2 surface area/well) and maintained as described above. On day 10 the cells were washed three times with PBS and equilibrated for 60 min with serum-free medium (2 ml/well). The medium was then replaced with fresh medium alone (negative control), medium containing 1% Triton X-100 (positive control), or medium containing the secretagogue. After 30 min the medium was removed and the cells were incubated with fresh medium for an additional 60 min. LDH released during both periods was measured spectrophotometrically at 340 nm using a kit (Sigma Chemical Co.). The amount of LDH released by the secretagogues was expressed as percent of the total cellular LDH, as determined by the paired positive controls. Release of 2 0.5% of the total cellular LDH was detectable.
For vital dye exclusion, cells were trypsinized (0.05% trypsin, 0.02% EDTA; 5 minm 370C) either immediately after stimulation or after the 60-min incubation period after stimulation, and viability was counted after addition of erythrosin B.
Immunocytochemistry. Serous cells were seeded on human placental collagen-coated coverslips and maintained and chased for 210 min as described above. After incubation with either serum-free medium alone or medium containing 10-8 M elastase, the cells were washed with PBS and fixed with paraformaldehyde-acetone (pH 6.6). Indirect immunofluorescence was performed as described previously (30) with the MAb CS-56 which recognizes chondroitin sulfate proteoglycan (31) . Mounted coverslips were examined and photographed using a fluorescence microscope (Carl Zeiss, Inc., Thornwood, NY).
Degranulation supernatant from human neutrophils. Human peripheral blood neutrophils were purified from the buffy coat fraction (Irwin Memorial Blood Bank, San Francisco, CA). Neutrophils were separated from monocytes and platelets by centrifugation (400 g, 40 min) through Ficoll-Paque (Pharmacia Fine Chemicals) and the remaining erythrocytes were lysed by hypotonic shock. The resulting cell population contained > 95% neutrophils and was 2 95% viable as determined by phase microscopy and vital dye exclusion (erythrosin B), respectively. The neutrophils were washed in calcium-and magnesium-free HBSS and resuspended in complete HBSS at a concentration of 0.6 X 108 cells/ml. Cells were activated by incubation with 5 ,ug/ml cytochalasin B and 10-6 M FMLP for 10 min at 37°C. Cell-free degranulation supernatant was prepared by centrifugation (400 g, 15 min) and stored at -70°C.
Measurements ofprotease activity. Cathepsin G-like activity and elastase-like activity were measured using succinyl-L-Ala-Ala-ProPhe-4-nitroanilide and succinyl-L-Ala-Ala-Pro-Val-4-nitroanilide, respectively. Reactions were carried out at 37°C in PBS (pH 7.4) with a substrate concentration of 80 ,ug/ml and monitored spectrophotometrically at 394 nm. Protease concentrations were calculated by comparison with the activity of purified proteases determined under identical conditions.
To determine the effect of protease inhibitors on the amidolytic activity, proteases were preincubated for 5 min either with PBS alone or with PBS containing the inhibitor.
Statistics. All values are expressed as mean±SEM. Statistical analysis was performed using analysis of variance and Newman-Keuls or Dunetts multiple comparison test, where appropriate (32) . A Pvalue of < 0.05 was considered significant.
Results
Basal secretion. Cultured serous cells secreted nondialyzable 35S-labeled macromolecules spontaneously and continuously.
After the 3.5-h chase, baseline secretion decreased by 19±2% between the consecutive 30-min sampling periods (n = 31). In the 210-to 240-min time period basal secretion per culture flask (25 cm2 surface area) averaged 1,920±275 cpm, equivalent to 2.2±0.25% of the total incorporated nondialyzable radiolabel (n = 10).
Secretion induced by human neutrophil proteases. Human neutrophil cathepsin G and neutrophil elastase both stimulated secretion of IIS-labeled macromolecules markedly (P < 0.0001) in a concentration-dependent fashion (Fig. 1) . The threshold concentration causing a significant increase of secretion over baseline was > 10-10 M for both cathepsin G and elastase. The maximal secretory response to both proteases was similar, although only the response to elastase reached a plateau at the concentrations used. Elastase was more potent than cathepsin G (P < 0.0001), with responses at 10-8 M of 1,810+60 and 970±20% above baseline, respectively (n = 5).
In contrast, histamine caused secretion with a threshold of 10-8 M and a maximal secretory response of only 185±8% at 10-5 M (P < 0.0001, n = 6). Addition of equal amounts of the vehicles of cathepsin G (0.22 M ammonium sulfate in 0.1 M sodium acetate, pH 5.0) and elastase (0.1 M sodium acetate, pH 5.0), respectively, had no effect on basal secretion (-5.5±7.5 and -5±4%, respectively; n = 5).
The secretion induced by neutrophil proteases was not cy- PMSF (240±85%; P < 0.01, n = 5) and was blocked completely by 10-5 M N-methoxysuccinyl-Ala-Ala-Pro-Val-chloromethylketone and by 100 ,g/ml a1-proteinase inhibitor (13±4 and -4±3%, respectively; P < 0.01, n = 5). The inhibitors had no effect on basal secretion (3±5, 14±8, 3±4, 0±5, and -1±2% for chymostatin (50 ug/ml), soybean trypsin inhibitor, PMSF, N-methoxysuccinyl-Ala-Ala-Pro-Val-chloromethylketone, and a1-proteinase inhibitor, respectively; n = S each). The inhibitory effect of the protease inhibitors on the protease-induced secretory response was similar to their effect on the amidolytic activity of the proteases. Thus, the amidolytic activity of cathepsin G was reduced 90% by 10 ,gg/ml chymostatin and > 90% (remaining activity below the limit of detection) by 50 Aig/ml chymostatin or 100 jsg/ml soybean trypsin inhibitor. The amidolytic activity ofelastase was inhibited 96% by 10-4 M PMSF and 2 99% by 10-' M N-methoxysuccinyl-Ala-Ala-Pro-Val-chloromethylketone or 100 ,tg/ml a1-proteinase inhibitor. This correlation between the protease inhibitor-induced reduction of the secretory response and the inhibition of the amidolytic activity suggests that the active catalytic site of the proteases is required for inducing a secretory response.
Analysis ofsecreted radiolabeled macromolecules. Gel filtration chromatography of basal secretions yielded a single peak in the void volume (Fig. 3 a) . Exclusion from Superose 6 in 4 M guanidine/0.5% CHAPS indicates the presence of high-molecular-weight (> 106D) glycoconjugates. Stimulation of secretion from serous cells with 10-6 M histamine increased the amount ofradiolabel eluting in this void volume peak (Fig.  3 a) . Similarly, stimulation of secretion with low concentrations of cathepsin G (3 X 10-9 M) or elastase (10-9 M) increased the amount of radiolabeled glycoconjugate eluting in the void volume (Fig. 3 b and c) . However, higher concentra- tions of the proteases caused not only an increase in the total amount of radiolabeled material secreted, but also a decrease in the average apparent molecular weight, suggesting degradation of secreted glycoconjugates. Glycosidase digestions of basal secretions (Fig. 4 a) and secretions induced by histamine (10-6 M; Fig. 4 b) , human neutrophil cathepsin G (lo-7 M; Fig. 4 c) , and elastase (1-' M; Fig. 4 d) gave identical results: chondroitinase ABC and AC shifted -90% of the radioactivity to the salt peak on Superose 6. These findings demonstrate that the radiolabeled glycoconjugate secreted under baseline conditions and in response to all three agonists is chondroitin sulfate proteoglycan.
Degradation of serous cell secretions by neutrophil proteases. To verify that the apparent lower molecular weight of protease-induced secretions was due to degradation, we examined the effect of neutrophil proteases on partially purified high molecular weight chondroitin sulfate. To obtain secreted proteoglycan unexposed to proteases, serous cells were stimulated with histamine (10-5 M) in the presence of the cAMPphosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (lo-5 M) to give a maximal histamine-induced response (unpublished observations). The secreted high-molecular-weight chondroitin sulfate proteoglycan was partially purified by Superose 6 gel filtration chromatography. Incubation of aliquots of this chondroitin sulfate proteoglycan with lo-7 M elastase and 10-6 M cathepsin G caused degradation, with a resulting molecular weight distribution (Fig. 5 ) similar to that of protease-induced secretions (Fig. 3 b and c) .
Cellular glycoconjugate pools. Gel filtration analysis ofglycoconjugates extracted from cell pellets of serous cells demon- strated the presence of two pools different in molecular size (Fig. 6 a) . In the case of unstimulated cells, -45% of the incorporated radiolabel eluted in the void volume of Superose 6. Molecular weight distribution and sensitivity to both chondroitinase ABC and AC (Fig. 6 b) (31) , resulted in punctate staining that spared the nucleus, suggesting that chondroitin sulfate was localized within cytoplasmic granules (Fig. 7 a) . Controls in which the primary or the secondary antibody was omitted showed no staining. Incubation of cells with 10-8 M elastase completely abolished punctate staining (Fig. 7 b) , suggesting that elastase had caused degranulation.
Secretion induced by degranulation supernatant from human neutrophils. Degranulation supernatant from human peripheral blood neutrophils stimulated secretion from cul- tured serous cells markedly. When degranulation supernatant from I05 neutrophils was added per ml of incubation medium of serous cells, the secretory response averaged 2,095±54% above baseline (n = 6, P < 0.0001). The response was partially inhibited by addition of l0-M N-methoxysuccinyl-Ala-AlaPro-Val-chloromethylketone (remaining response 363±22%) and was further reduced by addition of 50 ,g/ml chymostatin (102±19%). The magnitude of the secretory response to the final concentration of elastase (0.5 X 1o-8 M) and cathepsin G (10-9 M) in the incubation medium containing neutrophil supernatant, as determined by measurement ofamidolytic activity, agreed well with the responses obtained using the purified enzymes. Concentrations of cytochalasin B and FMLP equal to those present in supernatant from activated neutrophils had no effect on baseline secretion (-0±8%; n = 4).
Discussion
We demonstrated in this study that the human neutrophil proteases cathepsin G and elastase markedly stimulate degranulation of cultured tracheal gland serous cells. The secretory response to these proteases is noncytotoxic, requires catalytically active enzymes, and is > 10-fold larger than the secre- tory response evoked by agonists such as histamine. Cathepsin G and elastase in supernatant obtained by degranulation of human peripheral blood neutrophils cause a secretory response similar in magnitude to that caused by the purified enzymes. We also show that the neutrophil proteases degrade the predominant 35S-labeled serous cell secretory product, chondroitin sulfate proteoglycan. Thus, we provide the first evidence that neutrophil proteases cause degranulation of airway submucosal gland cells, the presumed major source of airway secretions in humans.
Together with the mast cell-derived protease chymase (24), neutrophil proteases are the most potent secretadgogues for cultured serous cells in regard to both threshold concentration and magnitude of the response. Concentrations of other agonists such as histamine, prostaglandins, and f3-adrenergic agonists in excess of 10-8 M are required to induce secretory responses (25, 33, 34) , whereas the threshold concentration for proteases (2 10-1 M) is lower by two orders of magnitude. Perhaps more significantly, proteases induce a maximal secretory response > 10-fold larger than that of other agonists, causing 2 80% depletion of 35S-labeled macromolecules from serous cells.
Suggestive in vivo evidence for an effect of proteases on submucosal glands has been reported in abstract form by Hahn et al. (35) . These investigators found that repeated intratracheal administration of porcine pancreatic elastase to ferrets in vivo increased the turnover of radiolabeled material in airway submucosal glands. Several lines of evidence have previously suggested an effect of proteases on cells of the airway surface layer. Elastases such as neutrophil elastase, pancreatic elastase, and Pseudomonas aeruginosa elastase, but not chymotryptic enzymes such as neutrophil cathepsin G or pancreatic chymotrypsin, release radiolabeled material from rabbit and hamster tracheal explants (36-38), tissues lacking submucosal glands (39) . Whether the release ofthis material is due primarily to protease-induced exocytosis or to hydrolysis of protease-sensitive molecules already present on the cell surface is not clear. Several studies provide light-and electron-microscopic evidence of protease-induced degranulation of goblet cells in vivo and in vitro (18, 37, 38) . However, other studies using cultured tracheal epithelial cells lacking secretory granules (19) , cultured epithelial cells with goblet-cell phenotype (20) , and tracheal explants (21) have shown protease-stimulated release ofglycoconjugates associated with the cell surface. In comparison to the concentrations of proteases needed to cause these effects on cells of the airway surface layer, the concentrations of neutrophil cathepsin G, elastase, and mast cell chymase (24) sufficient to produce a response in cultured serous cells (2 10`0 M = 3 ng/ml) are strikingly lower. The threshold concentration of neutrophil elastase for release of surface molecules from cultured hamster tracheal epithelial cells lies between 0.33 and 3.3 X 10-7 M (1-10 ,g/ml) (20) .
Thus, the threshold effects reported in the current study are seen at -1,000-fold lower concentrations of neutrophil elastase. The threshold concentrations we report are also lower than those of chymotrypsin and chymase (2 10-7 M) needed to cause degranulation ofrat peritoneal mast cells (40) , and are lower than the concentrations of cathepsin G (2 3 X 10-8 M) needed to induce platelet activation (41 The mechanism by which proteases stimulate degranulation of serous cells remains to be determined. Protease-induced degranulation of serous cells requires the active catalytic site of the proteases, as does cathepsin G-induced activation of platelets (41) and chymase-induced degranulation ofmast cells (45) . Thus, these serous cell secretagogue effects stand in contrast to reported noncatalytic effects of cathepsin G and elastase on endothelial cell injury (46) and albumin flux (47, 48) . Chymotryptic proteases related to cathepsin G, chymotrypsin, and chymase, have been known to cause degranulation of mast cells for > 25 yr (40, 49, 50) , but the mechanism of protease-induced mast cell activation is still unknown. Specific binding of chymotrypsin to mast cells does not occur, implying that the activation by chymotrypsin does not involve a simple ligand-receptor binding (45) . In contrast, low affinity binding sites for cathepsin G and elastase mediating endocytosis into macrophages and high affinity receptor binding sites for elastase on fibroblasts not mediating endocytosis have been described (51) (52) (53) . Intracellular proteases have been shown to be required for exocytosis and other cellular functions in some cells such as mast cells (54) (55) (56) (57) , so it is conceivable that exogenous proteases may mimic these endogenous proteases if they are endocytosed. Alternatively, the catalytic activity of the proteases may be directed at targets on the cell surface.
In addition to stimulating secretion, both cathepsin G and elastase degrade the secreted chondroitin sulfate proteoglycan, reducing the average molecular weight from > 106 D to an average of 3.5 X 105 D in the case of secretions stimulated by I0-' M elastase. The highly anionic nature of the secreted chondroitin sulfate proteoglycan (42) may facilitate this degradation by cationic neutrophil proteases (58) . The degradation of serous cell-derived chondroitin sulfate proteoglycan by neutrophil proteases is likely to cause an alteration of rheological properties, an increase of colloid osmotic pressure, and, possibly, the modification of biologic functions.
Neutrophils contain -2-4 gg cathepsin G (59, 60) and 1-2 jig elastase per 106 cells (61, 62) . Thus, the release of 10% of the proteases from 105 neutrophils/cm3 of submucosal tissue may be sufficient to cause a significant secretory response. Because the number of neutrophils found in the submucosa of dogs, particularly during airway inflammation, is considerably higher (0.5 X. 107/cm3 before and 2 X 107/cm3 after ozone exposure [4] ), a secretory response appears likely even if > 99% of the proteases are inhibited by endogenous antiproteases. In patients with cystic fibrosis and chronic bronchitis, conditions characterized by excessive and abnormal airway secretions, sputum concentrations of uninhibited cathepsin G and elastase are known to be increased markedly and to greatly exceed the concentrations used in this study (10) .
In summary, we have demonstrated that the neutrophil proteases cathepsin G and elastase are potent secretagogues for airway gland serous cells. In comparison to other agonists such as prostaglandins, histamine, and neurotransmitters, neutrophil proteases are more potent with respect to both threshold concentration and magnitude ofthe secretory response and are equipotent only to mast cell chymase. In addition, both proteases degrade the predominant secretory product, chondroitin sulfate proteoglycan. These results suggest a role for neutrophil proteases in the pathogenesis of increased and abnormal secretions associated with inflammatory airway diseases. In addition, because serous cells are the source of antileukoprotease (63), a potent protease inhibitor found in airway secretions, the sensitivity of serous cells to proteases provides a potential regulatory feedback mechanism in the defense of the airways.
